Logo image of IPI

INTREPID POTASH INC (IPI) Stock Fundamental Analysis

NYSE:IPI - New York Stock Exchange, Inc. - US46121Y2019 - Common Stock - Currency: USD

28.73  -0.35 (-1.2%)

After market: 28.73 0 (0%)

Fundamental Rating

3

IPI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 85 industry peers in the Chemicals industry. IPI has a great financial health rating, but its profitability evaluates not so good. IPI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year IPI has reported negative net income.
In the past year IPI had a positive cash flow from operations.
In multiple years IPI reported negative net income over the last 5 years.
IPI had a positive operating cash flow in each of the past 5 years.
IPI Yearly Net Income VS EBIT VS OCF VS FCFIPI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

IPI has a Return On Assets of -35.80%. This is amonst the worse of the industry: IPI underperforms 87.06% of its industry peers.
With a Return On Equity value of -44.87%, IPI is not doing good in the industry: 83.53% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -35.8%
ROE -44.87%
ROIC N/A
ROA(3y)-10.45%
ROA(5y)-0.74%
ROE(3y)-13.33%
ROE(5y)-1.79%
ROIC(3y)N/A
ROIC(5y)N/A
IPI Yearly ROA, ROE, ROICIPI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

Looking at the Gross Margin, with a value of 11.42%, IPI is doing worse than 77.65% of the companies in the same industry.
In the last couple of years the Gross Margin of IPI has declined.
The Profit Margin and Operating Margin are not available for IPI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.91%
GM growth 5Y-10.39%
IPI Yearly Profit, Operating, Gross MarginsIPI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

7

2. Health

2.1 Basic Checks

IPI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IPI has been increased compared to 1 year ago.
Compared to 5 years ago, IPI has less shares outstanding
Compared to 1 year ago, IPI has an improved debt to assets ratio.
IPI Yearly Shares OutstandingIPI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
IPI Yearly Total Debt VS Total AssetsIPI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

IPI has an Altman-Z score of 2.20. This is not the best score and indicates that IPI is in the grey zone with still only limited risk for bankruptcy at the moment.
IPI has a better Altman-Z score (2.20) than 68.24% of its industry peers.
IPI has a debt to FCF ratio of 0.05. This is a very positive value and a sign of high solvency as it would only need 0.05 years to pay back of all of its debts.
IPI has a better Debt to FCF ratio (0.05) than 98.82% of its industry peers.
IPI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
IPI has a better Debt to Equity ratio (0.00) than 94.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Altman-Z 2.2
ROIC/WACCN/A
WACC8.99%
IPI Yearly LT Debt VS Equity VS FCFIPI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 4.84 indicates that IPI has no problem at all paying its short term obligations.
IPI has a Current ratio of 4.84. This is amongst the best in the industry. IPI outperforms 92.94% of its industry peers.
IPI has a Quick Ratio of 1.86. This is a normal value and indicates that IPI is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of IPI (1.86) is better than 77.65% of its industry peers.
Industry RankSector Rank
Current Ratio 4.84
Quick Ratio 1.86
IPI Yearly Current Assets VS Current LiabilitesIPI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for IPI have decreased strongly by -87.50% in the last year.
IPI shows a decrease in Revenue. In the last year, the revenue decreased by -8.73%.
Measured over the past years, IPI shows a small growth in Revenue. The Revenue has been growing by 2.96% on average per year.
EPS 1Y (TTM)-87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.17%
Revenue 1Y (TTM)-8.73%
Revenue growth 3Y-1.96%
Revenue growth 5Y2.96%
Sales Q2Q%-1.51%

3.2 Future

IPI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.78% yearly.
Based on estimates for the next years, IPI will show a small growth in Revenue. The Revenue will grow by 1.86% on average per year.
EPS Next Y70.82%
EPS Next 2Y4.99%
EPS Next 3Y0.78%
EPS Next 5YN/A
Revenue Next Year1.86%
Revenue Next 2Y2.49%
Revenue Next 3Y1.86%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IPI Yearly Revenue VS EstimatesIPI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
IPI Yearly EPS VS EstimatesIPI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 -5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IPI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IPI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IPI Price Earnings VS Forward Price EarningsIPI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as IPI.
Based on the Price/Free Cash Flow ratio, IPI is valued a bit cheaper than the industry average as 76.47% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.32
EV/EBITDA 11.26
IPI Per share dataIPI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.99%
EPS Next 3Y0.78%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IPI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INTREPID POTASH INC

NYSE:IPI (4/21/2025, 4:15:00 PM)

After market: 28.73 0 (0%)

28.73

-0.35 (-1.2%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-03 2025-03-03/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners54.42%
Inst Owner Change0.61%
Ins Owners1.79%
Ins Owner Change0.86%
Market Cap380.10M
Analysts42.22
Price Target20.4 (-28.99%)
Short Float %2.73%
Short Ratio2.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-74.33%
Min EPS beat(2)-142.02%
Max EPS beat(2)-6.63%
EPS beat(4)0
Avg EPS beat(4)-366.68%
Min EPS beat(4)-1288.12%
Max EPS beat(4)-6.63%
EPS beat(8)0
Avg EPS beat(8)-247.72%
EPS beat(12)1
Avg EPS beat(12)-169.19%
EPS beat(16)3
Avg EPS beat(16)-126.02%
Revenue beat(2)2
Avg Revenue beat(2)19.34%
Min Revenue beat(2)9.74%
Max Revenue beat(2)28.94%
Revenue beat(4)4
Avg Revenue beat(4)20.69%
Min Revenue beat(4)9.74%
Max Revenue beat(4)28.94%
Revenue beat(8)8
Avg Revenue beat(8)24.17%
Revenue beat(12)11
Avg Revenue beat(12)19.32%
Revenue beat(16)15
Avg Revenue beat(16)19.04%
PT rev (1m)-4.76%
PT rev (3m)5.26%
EPS NQ rev (1m)-900%
EPS NQ rev (3m)-127.78%
EPS NY rev (1m)60%
EPS NY rev (3m)25.71%
Revenue NQ rev (1m)13.95%
Revenue NQ rev (3m)15.14%
Revenue NY rev (1m)-2.83%
Revenue NY rev (3m)-2.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.49
P/FCF 11.32
P/OCF 5.24
P/B 0.8
P/tB 0.85
EV/EBITDA 11.26
EPS(TTM)-0.45
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)2.54
FCFY8.84%
OCF(TTM)5.48
OCFY19.07%
SpS19.25
BVpS35.86
TBVpS33.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.8%
ROE -44.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.42%
FCFM 13.19%
ROA(3y)-10.45%
ROA(5y)-0.74%
ROE(3y)-13.33%
ROE(5y)-1.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.91%
GM growth 5Y-10.39%
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Debt/EBITDA 0.06
Cap/Depr 103.23%
Cap/Sales 15.28%
Interest Coverage N/A
Cash Conversion 237.76%
Profit Quality N/A
Current Ratio 4.84
Quick Ratio 1.86
Altman-Z 2.2
F-Score5
WACC8.99%
ROIC/WACCN/A
Cap/Depr(3y)154.88%
Cap/Depr(5y)113.05%
Cap/Sales(3y)19.65%
Cap/Sales(5y)14.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.17%
EPS Next Y70.82%
EPS Next 2Y4.99%
EPS Next 3Y0.78%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.73%
Revenue growth 3Y-1.96%
Revenue growth 5Y2.96%
Sales Q2Q%-1.51%
Revenue Next Year1.86%
Revenue Next 2Y2.49%
Revenue Next 3Y1.86%
Revenue Next 5YN/A
EBIT growth 1Y-4166.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1243.2%
EBIT Next 3Y132.29%
EBIT Next 5YN/A
FCF growth 1Y253.86%
FCF growth 3Y-17.26%
FCF growth 5YN/A
OCF growth 1Y67.7%
OCF growth 3Y-2.86%
OCF growth 5Y7.97%